Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 3,604 | 4,672 | 13,604 | 4,197 | 4,205 |
| Gross Profit | 3,604 | 4,672 | 13,604 | 4,197 | 4,205 |
| Operating Expenses | 63,571 | 62,430 | 63,759 | 66,960 | 46,713 |
| Operating Income | -59,967 | -57,758 | -50,155 | -62,763 | -42,508 |
| Other Income | 3,069 | 3,808 | 3,782 | 4,113 | 3,516 |
| Pre-tax Income | -56,898 | -53,950 | -46,373 | -58,650 | -38,992 |
| Income Tax | -135 | 75 | -113 | -313 | N/A |
| Net Income Continuous | -56,763 | -54,025 | -46,260 | -58,337 | -38,992 |
| Net Income | $-56,763 | $-54,025 | $-46,260 | $-58,337 | $-38,992 |
| EPS Basic Total Ops | -0.55 | -0.57 | -0.48 | -0.61 | -0.41 |
| EPS Basic Continuous Ops | -0.55 | -0.56 | -0.48 | -0.61 | -0.41 |
| EPS Diluted Total Ops | -0.55 | -0.57 | -0.48 | -0.61 | -0.41 |
| EPS Diluted Continuous Ops | -0.55 | -0.56 | -0.48 | -0.61 | -0.41 |
| EBITDA(a) | $-58,465 | $-56,690 | $-49,563 | $-62,537 | $-41,422 |